Specialities
Services
Resource Center
Pricing
About
Contact
If you’re evaluating a pain management billing company, the short answer is this: ask how they handle WISeR prior authorization, urine drug testing (UDT) compliance, interventional procedure coding, and denial appeals before you sign anything. Pain management practices lose more revenue to prior authorization gaps and UDT audit exposure than almost any other specialty, and most generic billing vendors simply aren’t built to catch it.
This isn’t a generic checklist. It’s built around what’s actually changed in 2026 — new federal prior authorization deadlines, a live Medicare pilot targeting your highest-volume procedures, and a wave of False Claims Act settlements tied specifically to pain clinics. If your current or prospective pain management billing company can’t answer these questions with specifics, that’s your answer.
Why Choosing the Right Pain Management Billing Company Matters More in 2026
Two federal changes made 2026 a turning point for pain management revenue cycle management. First, effective January 1, 2026, CMS’s interoperability and prior authorization final rule (CMS-0057-F) requires payers to decide standard prior authorization requests within seven calendar days and urgent requests within 72 hours, with a specific denial reason on every rejection.
Second, and more consequential for interventional pain practices, CMS launched the WISeR model on January 1, 2026. The model runs for six performance years from January 1, 2026 to December 31, 2031 in six states: New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington, and it specifically targets the procedures pain practices bill most: epidural steroid injections for pain management, percutaneous vertebral augmentation for the osteoarthritic knee, percutaneous image-guided lumbar decompression for spinal stenosis, and electrical nerve stimulators. Claims submitted without prior authorization in these six states now route to prepayment review instead of standard processing.
On top of that, UDT remains one of OIG’s most active enforcement areas in pain management. A Texas pain practice agreed to pay $13.6 million in December 2025 to resolve allegations of unnecessary urine drug testing billed to federal programs, and similar settlements have hit pain clinics in Florida, North Carolina, and Maryland in recent years. If your billing partner isn’t actively auditing UDT frequency and medical necessity documentation, you’re carrying that exposure alone.
Add the April 2026 NCCI Policy Manual update to the mix, which revised several bundling edits touching interventional pain codes, and you have three separate compliance layers most generic vendors were never built to track at once.
This is the environment your pain management billing company needs to operate in, not the one from five years ago. Practices that hire based on price alone, without confirming the vendor actually tracks these changes, tend to discover the gap only after a denial spike or an audit letter arrives.
Quick Comparison: What to Ask, and What the Answer Should Tell You
| Question Area | Weak Answer (Red Flag) | Strong Answer (What to Look For) |
| WISeR / prior auth handling | “We submit claims as usual” | Dedicated WISeR workflow with 120-day validity tracking and peer-to-peer request process |
| UDT compliance | “We bill what the provider orders” | Medical necessity review before submission, specimen validity edit checks |
| Interventional coding | “Our coders handle all specialties” | Certified coders with fluoroscopic guidance, bundling, and modifier-specific pain experience |
| Denial appeals | “We resubmit if it’s denied” | Root-cause tracking with targeted appeal letters and payer-specific documentation templates |
| Reporting | “Monthly PDF report” | Real-time dashboard with Days in AR, denial rate by CPT, and PA turnaround metrics |
| Contract terms | Flat percentage, no specialty clause | Transparent pricing tied to collections with interventional-procedure carve-outs |
1. How Do You Manage WISeR and Prior Authorization for Interventional Procedures?
If your practice sits in Arizona, New Jersey, Ohio, Oklahoma, Texas, or Washington, this is no longer optional due diligence, it’s the first question to ask. Ask exactly how the vendor tracks the 120-day authorization validity window, how quickly they can request a peer-to-peer review after a denial, and whether they’ve built payer-specific documentation templates for epidural steroid injections and nerve stimulator claims. A capable pain management billing company should be able to show you their first-pass PA approval rate, not just describe a process.
2. What’s Your Process for Urine Drug Testing Compliance?
Given the enforcement history, this question separates serious vendors from order-takers. Ask whether they review UDT orders against documented medical necessity before submission, how they handle specimen validity testing billed alongside UDT (a specific OIG audit target), and whether they flag testing frequency patterns that could trigger payer or federal scrutiny. This is one of the clearest points where Pain Management Billing Services either protect you or expose you.
3. Do Your Coders Have Interventional Pain-Specific Certification?
Pain management coding is not general medical billing. Facet joint injections, radiofrequency ablation, spinal cord stimulator trials, and epidural procedures each carry bundling rules, laterality requirements, and imaging-guidance modifiers that generic coders routinely miss. Ask for the specific credentials their coding team holds and how many years of interventional pain experience they carry, not just general medical billing and coding services experience.
4. How Do You Handle Denials, and What’s Your Root-Cause Process?
A vendor that simply resubmits denied claims is not managing your revenue cycle — they’re processing paperwork. Ask how they categorize denial reasons, whether they build payer-specific appeal templates, and what percentage of appealed claims they successfully overturn. This is where real RCM services differentiate themselves from clearinghouse-level billing.
5. What Reporting and Visibility Will I Actually Get?
You should be able to see Days in AR, clean claim rate, denial rate by CPT code, and WISeR turnaround times without asking for them. If the answer is “a monthly summary,” you won’t have the visibility to catch a slipping approval rate before it becomes a cash flow problem.
6. What Are Your Contract Terms, Onboarding Timeline, and Exit Clauses?
Ask how pricing is structured, whether interventional procedures carry different terms than office visits, what the onboarding timeline looks like, and what happens if you want to leave. Vendors offering true medical billing services should be transparent about all three before you sign. You can review typical engagement models and fee structures for pain management practices to compare against what you’re being offered.
7. Do You Support Payer Credentialing and Ongoing Compliance Training?
Credentialing delays are one of the most common, and most preventable, causes of stalled reimbursement for new pain management providers joining a practice. Ask whether the vendor manages payer enrollment and re-credentialing directly, and whether their staff receives regular training on evolving CMS rules like WISeR and the NCCI bundling updates. A pain management billing company that treats credentialing as an afterthought will leave new providers unable to bill for weeks at a time.
Get a Second Opinion on Your Current Billing Setup
Hiring the wrong vendor doesn’t usually show up immediately. It shows up three to six months later, in rising Days in AR, a growing denial backlog, or an audit letter you weren’t prepared for. If you’re unsure whether your current vendor can handle WISeR, UDT compliance, and interventional coding at the level your practice needs, request a Pain Management Billing Diagnostic.
Our team will review your denial patterns, PA turnaround times, and coding accuracy at no cost, and walk you through exactly where the gaps are. Call 888-357-3226 or email info@medicalbillersandcoders.com to schedule a review.
FAQs:
CMS has stated the model may expand to additional states and services over its six-year run, so practices outside the current pilot should still confirm their vendor has a prior authorization workflow ready.
Denial rates for pain procedures have been rising industry-wide, and each unresolved denial extends Days in AR and delays cash flow, particularly for high-volume interventional procedures.
UDT itself is a legitimate clinical tool; the risk comes from billing frequency, specimen validity bundling, and medical necessity documentation gaps, which is exactly where OIG enforcement has focused.
Look for certified coders with documented interventional pain experience, not just a general coding certification, since bundling and modifier rules in this specialty are unusually complex.
Onboarding timelines vary, but a well-run transition with clean data migration and payer credentialing review typically takes 30 to 60 days.
A Subject Matter Expert in healthcare billing operations with nearly 10 years of experience, sharing insights on claims processing, coding support, and revenue cycle optimization. Dedicated to educating healthcare professionals on compliance, accuracy, and strategies to improve billing performance.
